Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes
暂无分享,去创建一个
J. Navarro-González | J. Donate-Correa | A. Dusso | J. Cannata-Andía | J. Fernández-Martín | B. Martín-Carro | C. Mora-Fernández | N. Carrillo-López | Sara Panizo | C. Alonso-Montes | J. Martín-Vírgala | Sara Fernández-Villabrille | M. Naves-Diaz | M. Pérez-Basterrechea | Alejandra Fernández-Fernández
[1] Sha-Sha Li,et al. The controversy of klotho as a potential biomarker in chronic kidney disease , 2022, Frontiers in Pharmacology.
[2] Endeshaw Chekol Abebe,et al. Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications , 2022, Frontiers in Molecular Biosciences.
[3] A. Zubkiewicz-Kucharska,et al. Soluble Klotho Is Decreased in Children With Type 1 Diabetes and Correlated With Metabolic Control , 2021, Frontiers in Endocrinology.
[4] W. Rathmann,et al. Quantifying the underestimation of projected global diabetes prevalence by the International Diabetes Federation (IDF) Diabetes Atlas , 2021, BMJ Open Diabetes Research & Care.
[5] M. Saleem,et al. Role of Klotho in Hyperglycemia: Its Levels and Effects on Fibroblast Growth Factor Receptors, Glycolysis, and Glomerular Filtration , 2021, International journal of molecular sciences.
[6] T. Salvatore,et al. The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms , 2021, Frontiers in Medicine.
[7] J. Erusalimsky. The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes , 2021, Redox biology.
[8] K. Birkeland,et al. Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study , 2021, Diabetes Care.
[9] Zhongjie Sun,et al. Klotho Deficiency Causes Heart Aging via Impairing the Nrf2-GR Pathway. , 2020, Circulation research.
[10] J. Marshall,et al. Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes , 2020, Molecules.
[11] Akshay S. Desai,et al. NT‐proBNP by Itself Predicts Death and Cardiovascular Events in High‐Risk Patients With Type 2 Diabetes Mellitus , 2020, Journal of the American Heart Association.
[12] Jinghong Zhao,et al. The Protective Role of Klotho in CKD-Associated Cardiovascular Disease , 2020, Kidney Diseases.
[13] N. Vaziri,et al. Wnt signaling pathway in aging-related tissue fibrosis and therapies , 2020, Ageing Research Reviews.
[14] A. Banerjee,et al. Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study , 2020, Diabetes, obesity & metabolism.
[15] A. Giovino,et al. Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects , 2020, Oxidative medicine and cellular longevity.
[16] A. Papagianni,et al. Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis , 2019, BMC Nephrology.
[17] Ya Wang,et al. Exogenous H2S mitigates myocardial fibrosis in diabetic rats through suppression of the canonical Wnt pathway , 2019, International journal of molecular medicine.
[18] Youhua Liu,et al. Wnt/β-catenin signaling mediates both heart and kidney injury in type 2 cardiorenal syndrome. , 2019, Kidney international.
[19] Lin Sun,et al. A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy. , 2019, Advances in experimental medicine and biology.
[20] M. Kuro-o. The Klotho proteins in health and disease , 2018, Nature Reviews Nephrology.
[21] T. Yoo,et al. Klotho plays a protective role against glomerular hypertrophy in a cell cycle-dependent manner in diabetic nephropathy. , 2018, American journal of physiology. Renal physiology.
[22] K. Prasad. Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases? , 2018, Molecular and Cellular Biochemistry.
[23] M. Sánchez-Niño,et al. Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease , 2018, Diabetes Care.
[24] Z. Ni,et al. Klotho Reduces Necroptosis by Targeting Oxidative Stress Involved in Renal Ischemic-Reperfusion Injury , 2018, Cellular Physiology and Biochemistry.
[25] Masaya Takahashi,et al. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy. , 2017, Kidney international.
[26] Y. Higashimoto,et al. RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy , 2017, Diabetes.
[27] M. Bianchi,et al. The shedding-derived soluble receptor for advanced glycation endproducts sustains inflammation during acute Pseudomonas aeruginosa lung infection. , 2017, Biochimica et biophysica acta. General subjects.
[28] Techung Lee,et al. sFRP2 activates Wnt/β-catenin signaling in cardiac fibroblasts: differential roles in cell growth, energy metabolism, and extracellular matrix remodeling. , 2016, American journal of physiology. Cell physiology.
[29] N. Yılmaz,et al. Soluble Klotho and fibroblast growth factor 23 levels in diabetic nephropathy with different stages of albuminuria , 2016, Journal of Investigative Medicine.
[30] S. Sidhu,et al. Renal Production, Uptake, and Handling of Circulating αKlotho. , 2016, Journal of the American Society of Nephrology : JASN.
[31] J. Navarro-González,et al. Klotho in cardiovascular disease: Current and future perspectives. , 2015, World journal of biological chemistry.
[32] M. Mohammadi,et al. The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] J. Stewart,et al. Molecular mechanisms of AGE/RAGE-mediated fibrosis in the diabetic heart. , 2014, World journal of diabetes.
[34] Q. Yuan,et al. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin. , 2014, Diabetes research and clinical practice.
[35] B. Lanske,et al. The kidney is the principal organ mediating klotho effects. , 2014, Journal of the American Society of Nephrology : JASN.
[36] Y. Nabeshima,et al. Reduced Renal α-Klotho Expression in CKD Patients and Its Effect on Renal Phosphate Handling and Vitamin D Metabolism , 2014, PloS one.
[37] Youhua Liu,et al. Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling. , 2013, Journal of the American Society of Nephrology : JASN.
[38] M. Kuro-o,et al. Renal and extrarenal actions of Klotho. , 2013, Seminars in nephrology.
[39] C. Bondor,et al. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A. , 2012, Clinical biochemistry.
[40] Oliver Distler,et al. Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis , 2012, Nature Communications.
[41] D. Brazil,et al. CTGF/CCN2 activates canonical Wnt signalling in mesangial cells through LRP6: Implications for the pathogenesis of diabetic nephropathy , 2011, FEBS letters.
[42] Jai Radhakrishnan,et al. Pathologic classification of diabetic nephropathy. , 2010, Journal of the American Society of Nephrology : JASN.
[43] C. Kuo,et al. Augmented Wnt Signaling in a Mammalian Model of Accelerated Aging , 2007, Science.
[44] L. Leng,et al. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes , 2006, Diabetologia.
[45] H. Kaneto,et al. Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications. , 2005, Diabetes care.
[46] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.